Journal
/
/
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
JoVE Journal
Bioengineering
This content is Free Access.
JoVE Journal Bioengineering
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
DOI:

08:47 min

December 16, 2022

, , ,

Chapters

  • 00:04Introduction
  • 00:50Seeding of Cryopreserved Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
  • 01:25Dissociation and Counting of the Pre-Plated hiPSC-CMs
  • 02:49Flexible Hydrogel Substrates Preparation
  • 04:35Contraction Recording and Analysis
  • 06:52Results: Evaluation of CCM in 2D Human Stem Cell-Derived Cardiomyocytes
  • 07:59Conclusion

Summary

Automatic Translation

Here, we demonstrate a non-invasive cardiac medical device contractility evaluation method using 2D human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) monolayers, plated on a flexible substrate, coupled with video-based microscopy. This tool will be useful for the in vitro evaluation of the contractile properties of cardiac electrophysiology devices.

Related Videos

Read Article